Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Injuries | 13 | 2021 | 551 | 2.970 |
Why?
|
| Estrogens | 10 | 2021 | 173 | 2.260 |
Why?
|
| Calpain | 11 | 2022 | 205 | 1.850 |
Why?
|
| Spinal Cord | 8 | 2016 | 244 | 1.310 |
Why?
|
| Parkinson Disease | 2 | 2022 | 272 | 1.290 |
Why?
|
| Neuroprotective Agents | 7 | 2016 | 317 | 1.100 |
Why?
|
| Neurons | 5 | 2018 | 881 | 1.060 |
Why?
|
| Substantia Nigra | 3 | 2022 | 102 | 1.060 |
Why?
|
| Nerve Degeneration | 4 | 2015 | 134 | 1.010 |
Why?
|
| Dipeptides | 2 | 2015 | 89 | 1.000 |
Why?
|
| Rotenone | 1 | 2022 | 10 | 0.870 |
Why?
|
| Recovery of Function | 2 | 2016 | 506 | 0.840 |
Why?
|
| Apoptosis | 8 | 2018 | 1641 | 0.770 |
Why?
|
| Oxidative Stress | 2 | 2021 | 718 | 0.730 |
Why?
|
| Estradiol | 2 | 2016 | 176 | 0.720 |
Why?
|
| Osteoporosis | 1 | 2021 | 88 | 0.720 |
Why?
|
| Gliosis | 2 | 2016 | 51 | 0.600 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 15 | 0.550 |
Why?
|
| Rats | 11 | 2022 | 5300 | 0.530 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 35 | 0.530 |
Why?
|
| Animals | 21 | 2022 | 20880 | 0.530 |
Why?
|
| Dopaminergic Neurons | 3 | 2022 | 46 | 0.520 |
Why?
|
| Locomotion | 1 | 2016 | 135 | 0.510 |
Why?
|
| Parkinsonian Disorders | 1 | 2015 | 43 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 2083 | 0.490 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 86 | 0.470 |
Why?
|
| Glycoproteins | 1 | 2015 | 238 | 0.460 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 290 | 0.450 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 498 | 0.440 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 396 | 0.410 |
Why?
|
| Glioblastoma | 3 | 2018 | 219 | 0.340 |
Why?
|
| Triterpenes | 2 | 2018 | 40 | 0.280 |
Why?
|
| Alcoholism | 1 | 2015 | 1109 | 0.280 |
Why?
|
| Receptors, Estrogen | 2 | 2006 | 142 | 0.280 |
Why?
|
| Myelitis | 1 | 2005 | 9 | 0.270 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 116 | 0.260 |
Why?
|
| Electrophysiology | 1 | 2004 | 160 | 0.240 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 114 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 2550 | 0.230 |
Why?
|
| Caspase 3 | 4 | 2018 | 233 | 0.210 |
Why?
|
| Rats, Inbred Lew | 1 | 2022 | 150 | 0.210 |
Why?
|
| Glioma | 1 | 2003 | 140 | 0.200 |
Why?
|
| Male | 10 | 2018 | 37283 | 0.200 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 415 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2004 | 332 | 0.190 |
Why?
|
| Bone Remodeling | 1 | 2021 | 45 | 0.190 |
Why?
|
| Myelin Sheath | 2 | 2015 | 115 | 0.190 |
Why?
|
| Blotting, Western | 4 | 2015 | 954 | 0.190 |
Why?
|
| Microglia | 2 | 2015 | 143 | 0.180 |
Why?
|
| Cell Death | 2 | 2016 | 329 | 0.180 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 244 | 0.170 |
Why?
|
| Humans | 14 | 2022 | 68549 | 0.170 |
Why?
|
| Inflammation | 2 | 2016 | 1030 | 0.170 |
Why?
|
| Optic Neuritis | 1 | 1999 | 26 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2791 | 0.160 |
Why?
|
| Allyl Compounds | 1 | 2018 | 29 | 0.160 |
Why?
|
| Sulfides | 1 | 2018 | 43 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 99 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2021 | 2689 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1999 | 133 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 112 | 0.150 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 99 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2018 | 174 | 0.150 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 73 | 0.150 |
Why?
|
| Disease Progression | 1 | 2021 | 1037 | 0.150 |
Why?
|
| Caspases | 3 | 2015 | 194 | 0.140 |
Why?
|
| Astrocytes | 2 | 2018 | 270 | 0.140 |
Why?
|
| Autophagy | 1 | 2018 | 208 | 0.140 |
Why?
|
| Neuroprotection | 1 | 2016 | 28 | 0.130 |
Why?
|
| Gamma Rays | 1 | 2015 | 64 | 0.130 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 30 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2015 | 16 | 0.130 |
Why?
|
| Limonins | 1 | 2015 | 10 | 0.130 |
Why?
|
| Catechols | 1 | 2015 | 14 | 0.130 |
Why?
|
| Flavones | 1 | 2015 | 11 | 0.130 |
Why?
|
| Lanosterol | 1 | 2015 | 11 | 0.130 |
Why?
|
| Fatty Alcohols | 1 | 2015 | 14 | 0.130 |
Why?
|
| Exercise | 1 | 2021 | 658 | 0.130 |
Why?
|
| Heptanoic Acids | 1 | 2015 | 28 | 0.130 |
Why?
|
| Sesquiterpenes | 1 | 2015 | 41 | 0.130 |
Why?
|
| Necrosis | 1 | 2015 | 239 | 0.130 |
Why?
|
| Radiation Injuries | 1 | 2015 | 97 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2006 | 160 | 0.120 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 187 | 0.120 |
Why?
|
| Encephalitis | 1 | 2014 | 43 | 0.120 |
Why?
|
| Meningioma | 1 | 2015 | 54 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 105 | 0.120 |
Why?
|
| Axons | 1 | 2015 | 139 | 0.120 |
Why?
|
| Central Nervous System Depressants | 1 | 2015 | 182 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2004 | 111 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 102 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 163 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 778 | 0.100 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 435 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 647 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 411 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2006 | 791 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2016 | 1329 | 0.100 |
Why?
|
| Cytokines | 1 | 2015 | 866 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1070 | 0.090 |
Why?
|
| Ethanol | 1 | 2015 | 892 | 0.080 |
Why?
|
| Cell Survival | 2 | 2018 | 901 | 0.080 |
Why?
|
| DNA Fragmentation | 2 | 2018 | 85 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1745 | 0.070 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 20 | 0.070 |
Why?
|
| Boron Compounds | 1 | 2006 | 21 | 0.070 |
Why?
|
| Laminectomy | 1 | 2006 | 13 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2006 | 75 | 0.070 |
Why?
|
| Time Factors | 2 | 2006 | 4655 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 304 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 282 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 47 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2005 | 48 | 0.070 |
Why?
|
| Edema | 1 | 2005 | 66 | 0.060 |
Why?
|
| Brain | 1 | 2015 | 2176 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2004 | 24 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 144 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 48 | 0.060 |
Why?
|
| Receptors, Kainic Acid | 1 | 2004 | 24 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2004 | 200 | 0.060 |
Why?
|
| Cell Count | 1 | 2004 | 248 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 204 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 289 | 0.060 |
Why?
|
| Ionomycin | 1 | 2003 | 24 | 0.060 |
Why?
|
| Fura-2 | 1 | 2003 | 21 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2005 | 432 | 0.060 |
Why?
|
| Ionophores | 1 | 2003 | 25 | 0.060 |
Why?
|
| Spectrin | 1 | 2003 | 17 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 36 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2004 | 396 | 0.060 |
Why?
|
| Mice | 1 | 2015 | 8474 | 0.060 |
Why?
|
| Thiazoles | 1 | 2003 | 95 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 168 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1851 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 266 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 483 | 0.050 |
Why?
|
| Biomarkers | 1 | 2005 | 1593 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 597 | 0.040 |
Why?
|
| Age Factors | 1 | 2004 | 1860 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 929 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 1752 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2673 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 37 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2018 | 238 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1997 | 50 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 39 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1997 | 69 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 231 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 196 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 57 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 64 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 659 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 142 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 57 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 84 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2015 | 152 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 852 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2015 | 222 | 0.030 |
Why?
|
| Benzamides | 1 | 2015 | 156 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2005 | 7028 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 508 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1174 | 0.020 |
Why?
|
| Female | 1 | 2004 | 38021 | 0.010 |
Why?
|